The Atopic Dermatitis Countdown: Ready, Set, Go!
The University of Chicago via Independent
-
50
-
- Write review
Learn AI, Data Science & Business — Earn Certificates That Get You Hired
Master AI and Machine Learning: From Neural Networks to Applications
Overview
Google, IBM & Meta Certificates – 40% Off
One Coursera Plus subscription covers most Professional Certificates on Coursera.
Unlock All Certificates
The goal of this activity is to improve the identification and treatment of patients who are candidates for systemic or biologic agents for atopic dermatitis, including incorporation of new therapies.
Educational Partner: Medscape, LLC
Medium: Online Module
Commercial Support: Support for this activity has been provided through and independent educational grant from LEO Pharma A/S and LEO Pharma Inc.
Syllabus
After completing this activity, participants will be able to:
- Have increased knowledge regarding the
- Burden of atopic dermatitis;
- Role of interleukin (IL)-13 in the pathophysiology of atopic dermatitis;
- Current evidence for new and emerging biologic agents for the treatment of atopic dermatitis.